panda
Race in a Bottle
Heart failure
Public health, united states
Pharmaceutical industry
Chemotherapy
Drug therapy
Ethnology
Development
Medical care
Therapeutic use
Political aspects
African Americans
Social aspects
United States
History
Approved by the FDA in 2005 as the first drug with a race-specific indication on its label, BiDil was touted as a pathbreaking therapy to treat heart failure in black patients. Kahn reveals that, at the most basic level, BiDil became racial through legal maneuvering and commercial pressure as much a…
Not available to read online
This scan is restricted to patrons with print disabilities and can't be borrowed with a regular free account — signing up won't unlock it. Try Toronto Public Library, Libby, or Amazon above instead.
